Kohmann Bosshard Financial Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-65
Closed -$8.96K – 473
2025
Q4
$8.96K Buy
+65
New +$8.51K ﹤0.01% 856
2025
Q1
– Sell
-130
Closed -$12.7K – 623
2024
Q4
$12.7K Buy
+130
New +$13.9K ﹤0.01% 487

Other funds holding NVS

Kohmann Bosshard Financial Services's NVS Position: Q1 2026 in Review

Kohmann Bosshard Financial Services sold out of Novartis (NVS) in Q1 2026, closing a stake of 65 shares — an estimated $8.96K sold.

Kohmann Bosshard Financial Services first reported a position in NVS in Q4 2024 and held it in 2 quarters. The position peaked at $12.7K in Q4 2024. 1,604 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Kohmann Bosshard Financial Services reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
  • Kohmann Bosshard Financial Services sold 65 Novartis shares in Q1 2026, an estimated $8.96K.
  • Kohmann Bosshard Financial Services first reported a position in Novartis in Q4 2024 and held it in 2 quarters.
  • Kohmann Bosshard Financial Services's Novartis position peaked at $12.7K in Q4 2024.
  • 1,604 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Kohmann Bosshard Financial Services's 13F filing for Q1 2026, filed 23 Apr 2026.